Gender-specific differences in all-cause mortality between incomplete vs complete revascularization in patients with ST-elevation myocardial infarction and multi-vessel coronary artery disease
The American Journal of Cardiology Dec 16, 2017
Dimitriu-Leen AC, et al. - Patients who underwent either incomplete or complete revascularization for ST-elevation myocardial infarction (STEMI) and multi-vessel coronary artery disease (CAD) were assessed herein for gender-specific differences in all-cause mortality. Findings demonstrated that no gender-strategy differences occurred in all-cause mortality within 30 days post-STEMI. Not in women but in men who survived the first 30 days, an independent association of incomplete revascularization with all-cause mortality during 5-years follow-up was evident.
Methods
- Researchers included in this study 375 men and 115 women with a first STEMI and multi-vessel CAD without cardiogenic shock at admission or left main (LM) stenosis.
- They assessed 30-day and 5-year all-cause mortality in patients categorized according to gender and revascularization strategy (incomplete and complete revascularization).
Results
- Findings demonstrated that within the first 30 days, men and women with incomplete revascularization vs men with complete revascularization were associated with higher mortality rates.
- However, researchers found that when corrected for baseline characteristics and angiographic features, there was no independent association of the gender-strategy interaction variable with 30-day mortality post-STEMI.
- Furthermore, they noted that within the survivors of the first 30 days, men with incomplete revascularization (compared to men with complete revascularization) were independently related to all-cause mortality during 5 years follow-up (HR 3.07 [95%CI 1.24;7.61], P=0.016).
- In contrast, data reported no independent association of women with incomplete revascularization with 5-year all-cause mortality (HR 0.60 [95%CI 0.14;2.51], P=0.48).
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries